This drug wholesaler's transformation is paying off. Here's why the stock still looks attractive
The largest of America's three big drug wholesalers has outperformed the market this year, but is trading at a discount to its five-year median multiple.
AI brief
Pulse reads the full article- What happened
- Why it matters
- What to watch
Sign in to get the AI brief. Pulse explains what happened, why it matters, what to watch and who's exposed. Free for members.
Sign in to read the brief
